Senzime granted US Patent for OnZurf Probe
Press release: Uppsala, December 23, 2020. Senzime AB (publ) today announces that the company’s Patent application has been allowed for issuance as a patent for OnZurf Probe in the US. OnZurf is a microdialysis probe designed to monitor gastro-intestinal organs such as esophagus, stomach and liver. The OnZurf Probe was acquired by Senzime in 2016 and is based on an innovation by Dr. Pernilla Abrahamsson and clinical research at Umeå University. The development, including CE approval of OnZurf, was completed by Senzime in 2017. The probe is designed to enable continuous sampling